J&J and AstraZeneca Vie to Dominate New Era in Lung-Cancer Care

  • 📰 BNNBloomberg
  • ⏱ Reading Time:
  • 26 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 14%
  • Publisher: 50%

Health Health Headlines News

Health Health Latest News,Health Health Headlines

A rivalry is heating up between AstraZeneca Plc and Johnson & Johnson in lung cancer.

Turkey Sends Sweden NATO Membership Bill to ParliamentInvestors Find Value in Seemingly Valueless Convertible BondsJamaica Aims for Lower Borrowing Costs After Cutting Debt LoadHess’s Industry-Beating Valuation Is Sign of Investor ConfidenceAn Oil Giant Quietly Ditched the World’s Biggest Carbon Capture PlantBankrupt Cyxtera Looks to Sell Data Centers to BrookfieldCelebrity-Backed Baby Brand Hello Bello Files for BankruptcyChevron Will Discontinue Oil Hedging Once Hess Deal Is CompleteWhen...

Now Comes SummerOil holds near US$92 with Israel seen holding off invasion for nowBillionaire-Owned Africa Oil Driller Perenco Takes Coup in Its StrideA timeline of Bank of Canada rate hikesWhat are economists expecting from Wednesday's rate decision?BoC expected to hold key interest rate steady at 5% amid 'sluggish' economyRefinance or renew? How to choose when mortgage renewal creates sticker shockCanada retail sales are flat, cementing October rate pauseCanada retail sales flat,...

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 83. in HEALTH

Health Health Latest News, Health Health Headlines